CINA CHEST vs ClearRead CT
AI Verdict
Choose CINA CHEST if…
Choose CINA CHEST if your primary need is rapid, AI-powered triage and notification for life-threatening acute chest conditions like Pulmonary Embolism (PE) and Aortic Dissection (AD) in an emergency setting. This tool is ideal for quickly flagging suspected positive findings on CT angiography scans to assist radiologists in prioritizing critical cases and streamlining emergency workflows.
View CINA CHEST →Choose ClearRead CT if…
Choose ClearRead CT if your focus is on enhancing the detection, characterization, and tracking of pulmonary nodules, as well as performing coronary artery calcification (CAC) analysis on CT scans. This solution is best suited for improving diagnostic accuracy in lung cancer screening programs and for detailed follow-up of nodule changes over time, leveraging advanced vessel suppression technology.
View ClearRead CT →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CINA CHEST | ClearRead CT |
|---|---|---|
| Pricing | Subscription-based | Contact for pricing |
| Deployment | Cloud-based, On-premise (dedicated hardware), Virtualized (VM, Docker) | On-premise (stand-alone server, virtual machine) and Cloud |
| FDA Status | K210237 AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CINA CHESTCINA CHEST operates as a standalone web application and provides notifications with compressed preview images, suggesting a direct and potentially simpler user experience for its triage function. While ClearRead CT emphasizes seamless PACS integration and reduced reading time, CINA CHEST's standalone nature and notification system imply a more immediate and accessible interface for its specific purpose.
Clinical Value
CINA CHESTCINA CHEST focuses on the rapid detection and prioritization of life-threatening conditions like Pulmonary Embolism (PE) and Aortic Dissection (AD), which has immediate, high-impact clinical value in emergency settings. ClearRead CT, while valuable for pulmonary nodule detection and CAC scoring, addresses conditions that are generally less acute in their immediate presentation compared to the critical triage needs met by CINA CHEST.
Pricing & Value
TieBoth tools have opaque pricing models, requiring direct contact with the vendor for details. Without specific pricing information or detailed, quantifiable value metrics beyond general benefits, it is not possible to objectively determine a winner in this dimension.
Enterprise Readiness
ClearRead CTClearRead CT explicitly highlights 'Seamless PACS Integration / Vendor-neutral processing,' which is crucial for large-scale enterprise deployment and minimizing disruption to existing IT infrastructure. While CINA CHEST offers flexible deployment options and states HIPAA compliance, ClearRead CT's proven integration capabilities and operation within large healthcare institutions like the VA suggest a slightly higher degree of enterprise readiness.
Innovation
ClearRead CTClearRead CT features 'Patented Vessel Suppression (Clear Visual Intelligence)' technology, which represents a distinct and specific technological advancement to improve diagnostic accuracy by reducing visual clutter. While CINA CHEST utilizes deep learning for rapid triage, ClearRead CT's patented approach to image enhancement for nodule detection demonstrates a unique and specialized innovation.
Support & Docs
ClearRead CTRiverain Technologies' website for ClearRead CT explicitly mentions and provides access to various support resources, including a customer success hotline, FAQs, series recommendations, system requirements, workflows, and manuals. In contrast, Avicenna.AI's public information for CINA CHEST does not offer the same level of detailed, readily accessible support and documentation specifics.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CINA CHEST | ClearRead CT |
|---|---|---|
| Tool Name | CINA CHEST | ClearRead CT |
| Company | Avicenna.AI | RIVERAIN TECHNOLOGIES |
| Primary Use Case | AI-powered radiological triage and notification for rapid detection and prioritization of Pulmonary Embolism (PE) and Aortic Dissection (AD) on CT angiography scans. | AI suite for cardiothoracic health, enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. |
| Key Detections/Analysis | Pulmonary Embolism (PE) on Chest CT angiography, Aortic Dissection (AD) on Chest or Thoraco-abdominal CT angiography | Pulmonary Nodule Detection (solid, part-solid, ground glass), Coronary Artery Calcification (CAC) Scoring (ungated, non-contrast CTs) |
| Core Technology/Approach | Artificial intelligence (deep learning algorithms) | Advanced AI and patented Vessel Suppression (Clear Visual Intelligence) |
| Target Specialties | Cardiology, Emergency Medicine, Radiology | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring CINA CHEST and ClearRead CT.